Acute Myelogenous Leukemia Genetics, Biology and Therapy /
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2010.
|
Edición: | 1st ed. 2010. |
Colección: | Cancer Treatment and Research,
145 |
Temas: | |
Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- The Leukemia Stem Cell
- Epigenetic Mechanisms in AML - A Target for Therapy
- Chromosomal Translocations in AML: Detection and Prognostic Significance
- Chromosomal Deletions in AML
- Genes Predictive of Outcome and Novel Molecular Classification Schemes in Adult Acute Myeloid Leukemia
- Receptor Tyrosine Kinase Alterations in AML - Biology and Therapy
- Lineage-Specific Transcription Factor Aberrations in AML
- Proleukemic RUNX1 and CBF? Mutations in the Pathogenesis of Acute Leukemia
- Acute Myeloid Leukemia with Mutated Nucleophosmin (NPM1): Molecular, Pathological, and Clinical Features
- MicroRNAs: New Players in AML Pathogenesis
- Murine Models of Human Acute Myeloid Leukemia
- Apoptosis in Leukemias: Regulation and Therapeutic Targeting
- Acute Promyelocytic Leukemia: A Paradigm for Differentiation Therapy
- Immunotherapy of AML
- Therapy of Acute Myelogenous Leukemia in Adults.